CFM

Catalyst Funds Management Portfolio holdings

AUM $431M
1-Year Est. Return 48.17%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+48.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$431M
AUM Growth
-$228M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
598
New
Increased
Reduced
Closed

Top Buys

1
+$21.3M
2
+$14.3M
3
+$4.13M
4
J icon
Jacobs Solutions
J
+$3.67M
5
BWA icon
BorgWarner
BWA
+$2.68M

Top Sells

1
+$22.6M
2
+$22.3M
3
+$20.7M
4
MSFT icon
Microsoft
MSFT
+$17.7M
5
NVDA icon
NVIDIA
NVDA
+$10.6M

Sector Composition

1 Technology 28.32%
2 Healthcare 13.2%
3 Financials 12.49%
4 Industrials 11.45%
5 Materials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PK icon
301
Park Hotels & Resorts
PK
$2.29B
$185K 0.04%
17,700
INFU icon
302
InfuSystem Holdings
INFU
$191M
$165K 0.04%
18,400
VTRS icon
303
Viatris
VTRS
$17B
$156K 0.04%
12,500
-11,300
MNKD icon
304
MannKind Corp
MNKD
$906M
$154K 0.04%
27,235
REI icon
305
Ring Energy
REI
$313M
$147K 0.03%
168,500
PBI icon
306
Pitney Bowes
PBI
$1.62B
$133K 0.03%
+12,600
WEN icon
307
Wendy's
WEN
$1.39B
$130K 0.03%
15,600
CCC
308
CCC Intelligent Solutions
CCC
$3.72B
$124K 0.03%
15,630
BGS icon
309
B&G Foods
BGS
$454M
$121K 0.03%
28,200
NFBK icon
310
Northfield Bancorp
NFBK
$569M
$117K 0.03%
10,200
QIPT
311
Quipt Home Medical
QIPT
$162M
$112K 0.03%
31,845
NUS icon
312
Nu Skin
NUS
$364M
$111K 0.03%
11,585
NGD
313
New Gold Inc
NGD
$9.38B
$109K 0.03%
+12,500
MRAM icon
314
Everspin Technologies
MRAM
$245M
$107K 0.02%
11,570
LCTX icon
315
Lineage Cell Therapeutics
LCTX
$445M
$104K 0.02%
62,400
RC
316
Ready Capital
RC
$345M
$99.8K 0.02%
+45,800
SITC icon
317
SITE Centers
SITC
$329M
$89.2K 0.02%
+13,900
CCCC icon
318
C4 Therapeutics
CCCC
$291M
$81.2K 0.02%
42,500
BTG icon
319
B2Gold
BTG
$7.45B
$79.4K 0.02%
17,600
-65,200
LAC
320
Lithium Americas
LAC
$1.46B
$73.7K 0.02%
+16,900
THRY icon
321
Thryv Holdings
THRY
$138M
$66.5K 0.02%
+11,000
ABOS icon
322
Acumen Pharmaceuticals
ABOS
$201M
$62.5K 0.01%
29,600
JBLU icon
323
JetBlue
JBLU
$1.9B
$54.1K 0.01%
+11,900
NMRA icon
324
Neumora Therapeutics
NMRA
$532M
$53K 0.01%
29,600
LXRX icon
325
Lexicon Pharmaceuticals
LXRX
$669M
$46.3K 0.01%
40,300
11 12
13
14 15